LEADING ROLE OF INFECTION IN FORMATION OF PLACENTAL INSUFFICIENCY


Cite item

Full Text

Abstract

Aim. Evaluate the role of endotoxinemia in pregnancy complicated with placental insufficiency. Materials and methods. Complex clinical-laboratory examination of 130 pregnant women in 70 of which placental insufficiency was diagnosed (main group) was carried out. The examinees of the main group were divided into 3 subgroups: 36, 20 and 14 pregnant women with compensated, subcompensated and decompensated placental insufficiency, respectively. The control group was composed of 60 pregnant women with physiological course of gestation. Levels of LPS, LPS-binding protein and IgG against core-region, cytokines (TNF-α, IL10, IL2, IL4, IL6, IL8, IL10, IFNγ), C-reactive protein were determined in blood plasma. Infection by Сhlamydia trachomatis, Мycoplasma genitalium, Treponema vaginalis, Neisseria gonorrhoeae, Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum were evaluated by PCR. Results. In the main group in 64.2% of cases the presence of genital tract infection was established, in 47.0% - urinary system. An increase of LPS level, titers of IgG against LPS core-region and LPS-binding protein in blood plasma of pregnant women with placental insufficiency was shown. Cytokine profile in placental dysfunction was characterized by a significant increase of IL10, IL8, TNF-α Th1 cytokine and IL10 Th2 cytokine concentrations and a decrease of pro-inflammatory IL2, IFNγ levels. Conclusion. The results indicate a leading role of infection in formation of placental dysfunction as well as prove involvement of LPS Gram-negative bacteria in pathogenesis of this complication.

About the authors

K. R Bondarenko

Bashkiria State Medical University, Ufa, Russia

A. R Mavzyutov

Bashkiria State Medical University, Ufa, Russia

L. A Ozolinya

Pirogov Russian State University, Moscow, Russia

References

  1. Астраух Н.В., Сотникова Н.Ю., Крошкина Н.В. Особенности процессов активации и продукции регуляторных цитокинов на локальном уровне при гестозе. Медицинская иммунология. 2001, 2: 249-250.
  2. Левкович М. А. Современные представления о роли цитокинов в генезе физиологического и патологического течения беременности. Рос. вест. акушера-гинеколога. 2008, 8 (3): 37-40.
  3. Лиходед В.Г., Бондаренко В.М. Антиэндотоксиновый иммунитет в регуляции численности эшерихиозной микрофлоры кишечника. М., Медицина, 2007.
  4. Мавзютов А.Р., Бондаренко К.Р., Бондаренко В.М Бактериальный вагиноз: этиопато-генетические аспекты. Журн. микробиол. 2007, 6: 93-100.
  5. Останин А.А., Кустов С.М., Тыринова Т.В. и др. Показатели иммунитета беременных в раннем прогнозе развития фетоплацентарной недостаточности. Акушерство и гинекология. 2010, 1: 33-38.
  6. Посисеева Л.В., Сотникова Н.Ю. Иммунология беременности. Акушерство и гинекология. 2007, 5: 42-45.
  7. Тютюнник В.Л. Тактика ведения беременных при плацентарной недостаточности инфекционного генеза. Русский медицинский журнал. 2006, 14 (18): 1307-1310.
  8. Чистякова Г.Н., Газиева И.А., Ремизова И. И. и др. Оценка цитокинового профиля при физиологической и патологически протекающей беременности. Цитокины и воспаление. 2007, 6 (1): 3-8.
  9. Bizargity P., Del Rio R., Phillippe M. et al. Resistance to lipopolysaccharide-induced preterm delivery mediated by regulatory T cell function in mice. Biol. Reprod. 2009, 80 (5): 874-881.
  10. Girard S., Tremblay L., Lepage M. et al. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J. Immunol. 2010, 1; 184 (7): 3997-4005.
  11. Pennington K.A., Schlitt J.M., Jackson D.L. et al. Preeclampsia: multiple approaches for a multifactorial disease. Dis. Model. Mech. 2012, 5: 9-18.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Bondarenko K.R., Mavzyutov A.R., Ozolinya L.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies